Related Experiment Video
Updated: Aug 4, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Cerebrovascular Complications of COVID-19 on Venovenous Extracorporeal Membrane Oxygenation
Akram M Zaaqoq1, Matthew J Griffee2, Thu-Lan Kelly3
1Department of Critical Care Medicine, MedStar Washington Hospital Center, Georgetown University, Washington, DC.
Insights
Obesity and pre-extracorporeal membrane oxygenation (ECMO) vasopressor use increase stroke risk in COVID-19 patients on venovenous ECMO. Changes in carbon dioxide and oxygen levels post-ECMO also indicate higher stroke risk and mortality.
Area of Science:
- Critical care medicine
- Neurology
- Infectious diseases
Background:
- Cerebrovascular complications in COVID-19 patients requiring venovenous extracorporeal membrane oxygenation (ECMO) are not well-characterized.
- Understanding stroke prevalence and risk factors in this population is crucial for improving patient outcomes.
Purpose of the Study:
- To determine the prevalence and identify risk factors for stroke in adult COVID-19 patients supported by venovenous ECMO.
- To analyze the association between pre-ECMO and early post-ECMO physiological parameters and stroke development.
Main Methods:
- Analysis of prospectively collected data from the COVID-19 Critical Care Consortium (COVID Critical) registry.
- Inclusion of 595 adult COVID-19 patients on venovenous ECMO.
- Utilized univariable and multivariable survival modeling (Cox proportional hazards and Fine-Gray models) with competing risks.
Main Results:
- Stroke occurred in 7.2% of patients, with 83.7% being hemorrhagic.
- Obesity (aHR, 2.19) and pre-ECMO vasopressor use (aHR, 2.37) were significantly associated with increased stroke risk.
- Stroke patients exhibited greater relative decreases in PaCO2 and moderate increases in PaO2 within 48 hours of ECMO initiation.
- In-hospital mortality was substantially higher in patients who experienced stroke (79%) compared to those who did not (45%).
Conclusions:
- Obesity and pre-ECMO vasopressor use are significant risk factors for stroke in COVID-19 patients on venovenous ECMO.
- Specific changes in PaCO2 and PaO2 within 48 hours of ECMO initiation are associated with stroke development.
- Stroke in this population portends a significantly worse prognosis, underscoring the need for vigilant monitoring and management.
Objectives:
Evidence of cerebrovascular complications in COVID-19 requiring venovenous extracorporeal membrane oxygenation (ECMO) is limited. Our study aims to characterize the prevalence and risk factors of stroke secondary to COVID-19 in patients on venovenous ECMO.
Design:
We analyzed prospectively collected observational data, using univariable and multivariable survival modeling to identify risk factors for stroke. Cox proportional hazards and Fine-Gray models were used, with death and discharge treated as competing risks.
Setting:
Three hundred eighty institutions in 53 countries in the COVID-19 Critical Care Consortium (COVID Critical) registry.
Patients:
Adult COVID-19 patients who were supported by venovenous ECMO.
Interventions:
None.
Measurements And Main Results:
Five hundred ninety-five patients (median age [interquartile range], 51 yr [42-59 yr]; male: 70.8%) had venovenous ECMO support. Forty-three patients (7.2%) suffered strokes, 83.7% of which were hemorrhagic. In multivariable survival analysis, obesity (adjusted hazard ratio [aHR], 2.19; 95% CI, 1.05-4.59) and use of vasopressors before ECMO (aHR, 2.37; 95% CI, 1.08-5.22) were associated with an increased risk of stroke. Forty-eight-hour post-ECMO Pa co2 -pre-ECMO Pa co2 /pre-ECMO Pa co2 (relative ΔPa co2 ) of negative 26% and 48-hour post-ECMO Pa o2 -pre-ECMO Pa o2 /pre-ECMO Pa o2 (relative ΔPa o2 ) of positive 24% at 48 hours of ECMO initiation were observed in stroke patients in comparison to relative ΔPa co2 of negative 17% and relative ΔPa o2 of positive 7% in the nonstroke group. Patients with acute stroke had a 79% in-hospital mortality compared with 45% mortality for stroke-free patients.
Conclusions:
Our study highlights the association of obesity and pre-ECMO vasopressor use with the development of stroke in COVID-19 patients on venovenous ECMO. Also, the importance of relative decrease in Pa co2 and moderate hyperoxia within 48 hours after ECMO initiation were additional risk factors.
More Related Videos
Related Concept Videos
Hemodialysis II: Procedure and Complications
Venous Thrombosis III: Interprofessional Care
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

